Use of Blinatumomab for Relapse Therapy of B-Cell Precursor Acute Lymphoblastic Leukemia

被引：0
|
作者：
Pawinska-Wasikowska, K. [1 ,2 ]
Wyrobek, E. [2 ]
Klekawka, T. [1 ,2 ]
Luszawska-Kutrzeba, T. [2 ]
Garus, K. [2 ]
Pietrys, D. [2 ]
Zaniewska-Tekieli, A. [2 ]
Wieczorek, A. [1 ,2 ]
Balwierz, W. [1 ,2 ]
机构：
[1] Jagiellonian Univ, Coll Med, Dept Pediat Oncol & Hematol, Inst Pediat, Krakow, Poland
[2] Childrens Univ Hosp Krakow, Dept Pediat Oncol & Hematol, Krakow, Poland
来源：
PEDIATRIC BLOOD & CANCER | 2019年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V177 SIOP1
引用
收藏
页码：S251 / S251
页数：1
相关论文
共 50 条
  • [41] A phase 1b study of blinatumomab in Japanese children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Keizo Horibe
    Joan D. Morris
    Catherine A. Tuglus
    Cedric Dos Santos
    James Kalabus
    Abraham Anderson
    Hiroaki Goto
    Chitose Ogawa
    International Journal of Hematology, 2020, 112 : 223 - 233
  • [42] miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia
    Avigad, Smadar
    Verly, Iedan R. N.
    Lebel, Asaf
    Kordi, Oshrit
    Shichrur, Keren
    Ohali, Anat
    Hameiri-Grossman, Michal
    Kaspers, Gertjan J. L.
    Cloos, Jacqueline
    Fronkova, Eva
    Trka, Jan
    Luria, Drorit
    Kodman, Yona
    Mirsky, Hadar
    Gaash, Dafna
    Jeison, Marta
    Avrahami, Galia
    Elitzur, Sarah
    Gilad, Gil
    Stark, Batia
    Yaniv, Isaac
    GENES CHROMOSOMES & CANCER, 2016, 55 (04): : 328 - 339
  • [43] Precursor B-cell acute lymphoblastic leukemia presenting with isolated skin relapse: a pediatric case report
    Kar, Yeter Duzenli
    Ozdemir, Zeynep Canan
    Toret, Ersin
    Yilmaz, Evrim
    Bor, Ozcan
    EGYPTIAN PEDIATRIC ASSOCIATION GAZETTE, 2023, 71 (01)
  • [44] Precursor B-cell acute lymphoblastic leukemia presenting with isolated skin relapse: a pediatric case report
    Yeter Düzenli Kar
    Zeynep Canan Özdemir
    Ersin Töret
    Evrim Yılmaz
    Özcan Bör
    Egyptian Pediatric Association Gazette, 71
  • [45] FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease
    Jen, Emily Y.
    Xu, Qing
    Schetter, Aaron
    Przepiorka, Donna
    Shen, Yuan Li
    Roscoe, Donna
    Sridhara, Rajeshwari
    Deisseroth, Albert
    Philip, Reena
    Farrell, Ann T.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2019, 25 (02) : 473 - 477
  • [46] Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
    Kantarjian, Hagop M.
    Zugmaier, Gerhard
    Brueggemann, Monika
    Wood, Brent L.
    Horst, Heinz A.
    Zeng, Yi
    Martinelli, Giovanni
    CANCERS, 2021, 13 (22)
  • [47] A Phase 1/2 Study Of Blinatumomab In Pediatric Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
    von Stackelberd, Arend
    Zugmaier, Gerhard
    Handgretinger, Rupert
    Locatelli, Franco
    Rizzari, Carmelo
    Trippett, Tanya M.
    Borkhardt, Arndt
    Rheingold, Susan R.
    Bader, Peter
    Bhojwani, Deepa
    Cooper, Todd Michael
    DuBois, Steven G.
    O'Brien, Maureen M.
    Zwaan, Christian M.
    Holland, Chris
    Mergen, Noemi
    Fischer, Anja
    Zhu, Min
    Hijazi, Youssef
    Whitlock, James
    Gore, Lia
    BLOOD, 2013, 122 (21)
  • [48] Genomic Determinants of Response to Blinatumomab in Relapsed/Refractory (R/R) B-Cell Precursor Acute Lymphoblastic Leukemia in Adults
    Zhao, Yaqi
    Aldoss, Ibrahim
    Qu, Chunxu
    Marcucci, Guido
    Stein, Anthony S.
    Bhatia, Ravi
    Mullighan, Charles G.
    Forman, Stephen J.
    Roberts, Kathryn G.
    BLOOD, 2018, 132
  • [49] Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia
    Locatelli, Franco
    Whitlock, James A.
    Peters, Christina
    Chen-Santel, Christiane
    Chia, Victoria
    Dennis, Robyn M.
    Heym, Kenneth M.
    Katz, Aaron J.
    Kelsh, Michael A.
    Sposto, Richard
    Tu, Huakang
    Tuglus, Catherine A.
    Verma, Anupam
    Vinti, Luciana
    Wilkes, Jennifer J.
    Zubarovskaja, Nathalya
    Zugmaier, Gerhard
    von Stackelberg, Arend
    Sun, Weili
    LEUKEMIA, 2020, 34 (09) : 2473 - 2478
  • [50] Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia
    Franco Locatelli
    James A. Whitlock
    Christina Peters
    Christiane Chen-Santel
    Victoria Chia
    Robyn M. Dennis
    Kenneth M. Heym
    Aaron J. Katz
    Michael A. Kelsh
    Richard Sposto
    Huakang Tu
    Catherine A. Tuglus
    Anupam Verma
    Luciana Vinti
    Jennifer J. Wilkes
    Nathalya Zubarovskaja
    Gerhard Zugmaier
    Arend von Stackelberg
    Weili Sun
    Leukemia, 2020, 34 : 2473 - 2478
12345